What Does DNA Capital Do?

Total employees18
HeadquartersSão Paulo
Founded2009

DNA Capital is a global healthcare-focused investment firm founded in 2013. With a significant presence in both North America and Latin America, the firm partners with exceptional entrepreneurs to build transformative companies across various healthcare sectors, including healthtech, biotech, pharmaceutical services, and medical devices. DNA Capital leverages its deep industry expertise, extensive network, and operational capabilities to support its portfolio companies in achieving scalable growth and making a meaningful impact on healthcare delivery and innovation.

Where Is DNA Capital's Headquarters?

HQ Function

Serves as a central hub for DNA Capital's investment activities in Latin America, including deal origination, due diligence, portfolio company management, and fostering relationships within the regional healthcare and innovation ecosystem.

Notable Features:

Modern office facilities situated in a prime business district, designed to foster collaboration, strategic planning, and engagement with the local market.

Work Culture:

Characterized by a dynamic, entrepreneurial, and highly collaborative environment. The team is driven by a passion for advancing healthcare through innovation and a commitment to providing hands-on support to portfolio companies. Emphasis is placed on deep market analysis, strategic insights, and value creation.

HQ Significance:

Its São Paulo location is strategically important for tapping into Latin America's burgeoning healthcare market, accessing a vibrant pool of entrepreneurial talent, and capitalizing on co-investment opportunities within one of the region's largest financial and innovation centers.

Values Reflected in HQ: The headquarters' design and operations mirror DNA Capital's core values of excellence, integrity, partnership, and a forward-thinking approach to healthcare investment.

Location:

DNA Capital operates with a focused global investment strategy in healthcare, primarily centered on North America and Latin America. Key operational offices in São Paulo, Brazil, and Miami, USA, are complemented by a strategic presence in San Francisco. This structure enables the firm to effectively source investment opportunities, conduct thorough due diligence, provide hands-on support to its diverse portfolio companies across these geographies, and connect with global healthcare innovation trends and investor networks.

Street Address:

Av. Brigadeiro Faria Lima, 3477 - Torre B - 12º andar - Itaim Bibi

City:

São Paulo

State/Province:

SP

Country:

Brazil

Where Else Does DNA Capital Operate Around the World?

Miami, Florida, USA

Address: 200 S. Biscayne Blvd, Suite 2770, Miami, FL 33131

To identify and partner with high-growth healthcare companies in North America, leverage cross-border synergies with Latin American markets, and engage with U.S.-based limited partners and strategic collaborators.

San Francisco, California, USA

Address: [Strategic presence; specific office address not publicly listed]

To facilitate deal sourcing, networking with entrepreneurs and venture partners, identify emerging technologies, and support portfolio companies with interests or operations on the West Coast.

Buying Intent Signals for DNA Capital

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading DNA Capital? Meet the Executive Team

As of April 2025, DNA Capital' leadership includes:

Marcos Lutz - Co-Founder & Managing Partner
Pedro Bueno - Co-Founder & Managing Partner
Stephen Bloch, MD - Managing Partner
Meera Clark - Partner
Fernando Cembranelli - Partner
Silvia Ragazzo - Partner, Head of Investor Relations
Alan Milinazzo - Operating Partner

Who's Investing in DNA Capital?

DNA Capital has been backed by several prominent investors over the years, including:

As a private investment firm, DNA Capital's Limited Partners (LPs), who invest in its funds, are typically confidential and not publicly disclosed. These LPs often include institutional investors such as endowments, foundations, pension funds, and family offices.

What Leadership Changes Has DNA Capital Seen Recently?

Hire2
Exits0

DNA Capital strengthened its team in the past 12 months with key strategic hires, including a new Partner and Head of Investor Relations, and an Operating Partner, enhancing its capabilities in investor relations and portfolio company support. No major publicly disclosed departures from the senior executive team were noted during this period.

New Appointments:

Silvia Ragazzo, Silvia Ragazzo appointed as Partner and Head of Investor Relations.
Alexandre Vilela (Zaza), Alexandre Vilela (Zaza) appointed as Operating Partner.

What Technology (Tech Stack) Is Used byDNA Capital?

Discover the tools DNA Capital uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

DNA Capital Email Formats and Examples

DNA Capital likely utilizes common professional email formats. Based on industry standards and observed patterns for similar firms, primary formats often include a combination of the employee's first name and last name, or first initial and last name.

first.last@dnacapital.com or firstinitiallast@dnacapital.com

Format

jane.doe@dnacapital.com or jdoe@dnacapital.com

Example

85%

Success rate

What's the Latest News About DNA Capital?

Business WireNovember 15, 2023

Jasper Health Secures $25 Million in Series A Extension Funding Led by DNA Capital to Advance AI-Powered Cancer Care Navigation

Jasper Health, an AI-powered cancer care navigation platform, announced a $25 million Series A extension funding round led by DNA Capital. This investment aims to help Jasper Health enhance its platform capabilities and expand its reach to more patients and healthcare providers....more

PR NewswireJune 20, 2023

Alinea Health Raises $6.2M Series A Led by DNA Capital to Expand Access to Specialized Women's Health

Alinea Health, a company dedicated to improving access to specialized women's healthcare, secured a $6.2 million Series A funding round with DNA Capital as the lead investor. The funds are intended to support the expansion of Alinea Health's services and its operational footprint....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including DNA Capital, are just a search away.